FMO3 and coronary artery disorder: Some of these genes had limited studies with pharmacology of CAD including ALDH2 [67], APOC1 ([68]), FMO3 [69], LEPR [70], P2RY12 [71], SCARB1 [72], SH2B3 [73], SLCO1B1 [74], TLR4 [75], EDN1 [76], NOS3 [77], ABCG8 [78], AGT [79], FABP1 [80], KDR [81], NPPA [82], NR3C2 [83], NT5C2 [84], and PTGS1 [85].